|
1
|
Zheng ZX, Zheng RS, Zhang SW and Chen WQ:
Colorectal cancer incidence and mortality in China, 2010. Asian Pac
J Cancer Prev. 15:845–460. 2014. View Article : Google Scholar
|
|
2
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:10–17.
2014. View Article : Google Scholar
|
|
3
|
Cascinu S, Georgoulias V, Kerr D, Maughan
T, Labianca R and Ychou M: Colorectal cancer in the adjuvant
setting: Perspectives on treatment and the role of prognostic
factors. Ann Oncol. 14(Suppl 2): ii25–ii29. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ovaska J, Järvinen H, Kujari H, Perttilä I
and Mecklin JP: Follow-up of patients operated on for colorectal
carcinoma. Am J Surg. 159:593–596. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bernier I and Jollès P: Purification and
characterization of a basic 23 kDa cytosolic protein from bovine
brain. Biochim Biophys Acta. 790:174–181. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hori N, Chae KS, Murakawa K, Matoba R,
Fukushima A, Okubo K and Matsubara K: A human cDNA sequence
homologue of bovine phosphatidylethanolamine-binding protein. Gene.
140:293–294. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Seddiqi N, Bollengier F, Alliel PM, Périn
JP, Bonnet F, Bucquoy S, Jollès P and Schoentgen F: Amino acid
sequence of the Homo sapiens brain 21–23-kDa protein
(neuropolypeptide h3), comparison with its counterparts from Rattus
norvegicus and Bos taurus species, and expression of its mRNA in
different tissues. J Mol Evol. 39:655–660. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yeung K, Seitz T, Li S, Janosch P,
McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, et
al: Suppression of Raf-1 kinase activity and MAP kinase signalling
by RKIP. Nature. 401:173–177. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li HZ, Gao Y, Zhao XL, Liu YX, Sun BC,
Yang J and Yao Z: Effects of raf kinase inhibitor protein
expression on metastasis and progression of human breast cancer.
Mol Cancer Res. 7:832–840. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fu Z, Smith PC, Zhang L, Rubin MA, Dunn
RL, Yao Z and Keller ET: Effects of raf kinase inhibitor protein
expression on suppression of prostate cancer metastasis. J Natl
Cancer Inst. 95:878–889. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li HZ, Wang Y, Gao Y, Shao J, Zhao XL,
Deng WM, Liu YX, Yang J and Yao Z: Effects of raf kinase inhibitor
protein expression on metastasis and progression of human
epithelial ovarian cancer. Mol Cancer Res. 6:917–928. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fu Z, Kitagawa Y, Shen R, Shah R, Mehra R,
Rhodes D, Keller PJ, Mizokami A, Dunn R, Chinnaiyan AM, et al:
Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a
novel prognostic marker in prostate cancer. Prostate. 66:248–256.
2006. View Article : Google Scholar
|
|
13
|
Al-Mulla F, Hagan S, Behbehani AI, Bitar
MS, George SS, Going JJ, García JJ, Scott L, Fyfe N, Murray GI, et
al: Raf kinase inhibitor protein expression in a survival analysis
of colorectal cancer patients. J Clin Oncol. 24:5672–5679. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu YF, Yi Y, Qiu SJ, Gao Q, Li YW, Dai CX,
Cai MY, Ju MJ, Zhou J, Zhang BH, et al: PEBP1 downregulation is
associated to poor prognosis in HCC related to hepatitis B
infection. J Hepatol. 53:872–879. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jia B, Liu H, Kong Q and Li B: RKIP
expression associated with gastric cancer cell invasion and
metastasis. Tumour Biol. 33:919–925. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li J, Wang Y, Song Y, Fu Z and Yu W:
miR-27a regulates cisplatin resistance and metastasis by targeting
RKIP in human lung adenocarcinoma cells. Mol Cancer. 13:1932014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Doyle B, Hagan S, Al-Mulla F, Scott L,
Harden S, Paul J, Mulcahy H, Murray GI, Sheahan K, O'Sullivan J, et
al: Raf kinase inhibitor protein expression combined with
peritoneal involvement and lymphovascular invasion predicts
prognosis in Dukes' B colorectal cancer patients. Histopathology.
62:505–510. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Minoo P, Zlobec I, Baker K, Tornillo L,
Terracciano L, Jass JR and Lugli A: Loss of raf-1 kinase inhibitor
protein expression is associated with tumor progression and
metastasis in colorectal cancer. Am J Clin Pathol. 127:820–827.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zlobec I, Baker K, Minoo P, Jass JR,
Terracciano L and Lugli A: Node-negative colorectal cancer at high
risk of distant metastasis identified by combined analysis of lymph
node status, vascular invasion, and Raf-1 kinase inhibitor protein
expression. Clin Cancer Res. 14:143–148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun J, Luo Y, Tian Z, Gu L, Xia SC and Yu
Y: Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid
cystic carcinoma and its clinicopathological relevance. BMC Cancer.
12:4992012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu Y, Chen W, Zhang Y, Hamburger AW, Pan H
and Zhang Z: Suppression of salivary adenoid cystic carcinoma
growth and metastasis by ErbB3 binding protein Ebp1 gene transfer.
Int J Cancer. 120:1909–1913. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Albini A: Tumor and endothelial cell
invasion of basement membranes. The Matrigel chemoinvasion assay as
a tool for dissecting molecular mechanisms. Pathol Oncol Res.
4:230–241. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Maeda H, Segawa T, Kamoto T, Yoshida H,
Kakizuka A, Ogawa O and Kakehi Y: Rapid detection of candidate
metastatic foci in the orthotopic inoculation model of
androgen-sensitive prostate cancer cells introduced with green
fluorescent protein. Prostate. 45:335–340. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang S, Jean D, Luca M, Tainsky MA and
Bar-Eli M: Loss of AP-2 results in downregulation of c-KIT and
enhancement of melanoma tumorigenicity and metastasis. EMBO J.
17:4358–4369. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang L, Fu Z, Binkley C, Giordano T,
Burant CF, Logsdon CD and Simeone DM: Raf kinase inhibitory protein
inhibits beta-cell proliferation. Surgery. 136:708–715. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yeung KC, Rose DW, Dhillon AS, Yaros D,
Gustafsson M, Chatterjee D, McFerran B, Wyche J, Kolch W and Sedivy
JM: Raf kinase inhibitor protein interacts with NF-kappaB-inducing
kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol.
21:7207–7217. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang H, Park S, Sun SC, Trumbly R, Ren G,
Tsung E and Yeung KC: RKIP inhibits NF-kappaB in cancer cells by
regulating upstream signaling components of the IkappaB kinase
complex. FEBS Lett. 584:662–668. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Corbit KC, Trakul N, Eves EM, Diaz B,
Marshall M and Rosner MR: Activation of Raf-1 signaling by protein
kinase C through a mechanism involving Raf kinase inhibitory
protein. J Biol Chem. 278:13061–13068. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lorenz K, Lohse MJ and Quitterer U:
Protein kinase C switches the Raf kinase inhibitor from Raf-1 to
GRK-2. Nature. 426:574–579. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Al-Mulla F, Bitar MS, Al-Maghrebi M,
Behbehani AI, Al-Ali W, Rath O, Doyle B, Tan KY, Pitt A and Kolch
W: Raf kinase inhibitor protein RKIP enhances signaling by glycogen
synthase kinase-3β. Cancer Res. 71:1334–1343. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xinzhou H, Ning Y, Ou W, Xiaodan L, Fumin
Y, Huitu L and Wei Z: RKIp inhibits the migration and invasion of
human prostate cancer PC-3M cells through regulation of
extracellular matrix. Mol Biol. 45:1004–1011. 2011. View Article : Google Scholar
|
|
32
|
Yousuf S, Duan M, Moen EL, Cross-Knorr S,
Brilliant K, Bonavida B, LaValle T, Yeung KC, Al-Mulla F, Chin E,
et al: Raf kinase inhibitor protein (RKIP) blocks signal transducer
and activator of transcription 3 (STAT3) activation in breast and
prostate cancer. PLoS One. 9:e924782014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee J, Lee J, Farquhar KS, Yun J,
Frankenberger CA, Bevilacqua E, Yeung K, Kim EJ, Balázsi G and
Rosner MR: Network of mutually repressive metastasis regulators can
promote cell heterogeneity and metastatic transitions. Proc Natl
Acad Sci USA. 111:E364–E373. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun M, Gomes S, Chen P, Frankenberger CA,
Sankarasharma D, Chung CH, Chada KK and Rosner MR: RKIP and HMGA2
regulate breast tumor survival and metastasis through lysyl oxidase
and syndecan-2. Oncogene. 33:3528–3537. 2014. View Article : Google Scholar :
|
